Data from the present study also show a low frequency of co-occurrence of CCND1 amplification with the above common mutations, supporting the opinion that CCND1 amplification should be considered an independent genomic subtype in melanoma and may have unique biological characteristics. The gene discussed is CCND1; the disease is melanoma.